Categories |
PHARMACEUTICALS
VACCINES
THERAPEUTICS
BIOTECHNOLOGY
|
Call for Papers |
|
This conference series brings together senior thought leaders from across multiple disciplines to discuss strategies, technologies and capabilities that accelerate biopharmaceutical development. The theme of the AccBio 2023 is "Applying enduring lessons from the pandemic, including accelerated development of a broad range of vaccines and therapeutics”.
Session topics include: Enduring Lessons Learned From the Pandemic Accelerating Development Using Predictive Technologies Fast to Patients: Beyond mAb to new Modalities KEYNOTE SPEAKERS Rachel Chikwamba, South African Council for Scientific and Industrial Research Raymond Deshaies, Amgen Kevin Eggan, BioMarin Pharmaceutical Inc. Alison Moore, Allogene CONFERENCE CHAIRS Glen Bolton, Amgen Ganesh Vedantham, BioMarin ORGANIZING COMMITTEE Dana Anderson, Denali Therapeutics Hanne Bak, Regeneron Katy Barglow, 4D Molecular Therapeutics Tim Charlebois, University of Delaware Charles Cooney, Massachusetts Institute ofTechnology Rohini Deshpande, Amgen Chetan Goudar, Amgen Aine Hanly, Vir Biotechnology Brendan Hughes, BMS Brian Kelley, Vir Biotechnology Kelvin Lee, University of Delaware J. Christopher Love, Massachusetts Institute of Technology Greg Naugle, GSK Gregg Nyberg, Landmark Bio Stefanie Pluschkell, In Scope Coaching and Consulting Arup Roy, Eli Lilly Cleo Salisburt, Genentech Jeff Salm, Pfizer Gene Schaefer, University of Delaware Who should attend: -VP- to CEO-level thought leaders from the biopharmaceutical development and manufacturing fields -Senior-level researchers from industry, government, and academia -R&D leaders -Program managers and industry executives -Associated professionals in the fields of bioengineering, biotechnology, and bioprocessing Register by July 26 for best rates! Conference organized by the Society for Biological Engineering |
Summary |
|
AccBio 2023 : 8th International Conference on Accelerating Biopharmaceutical Development (AccBio 2023) will take place in Cambridge, MA. It’s a 3 days event starting on Sep 6, 2023 (Wednesday) and will be winded up on Sep 8, 2023 (Friday). AccBio 2023 falls under the following areas: PHARMACEUTICALS, VACCINES, THERAPEUTICS, BIOTECHNOLOGY, etc. Submissions for this Conference can be made by Jun 12, 2023. Authors can expect the result of submission by Jun 12, 2023. Upon acceptance, authors should submit the final version of the manuscript on or before Jun 12, 2023 to the official website of the Conference. Please check the official event website for possible changes before you make any travelling arrangements. Generally, events are strict with their deadlines. It is advisable to check the official website for all the deadlines. Other Details of the AccBio 2023
|
Credits and Sources |
| [1] AccBio 2023 : 8th International Conference on Accelerating Biopharmaceutical Development (AccBio 2023) |
